Info Obat dan Regulator Obat Dunia

E
Accelerating Clinical Trials in the EU (ACT EU): for better clinical trials that address patients’ needs, , 13/01/2022
Replies
0
Views
500
EMA
E
E
EMA welcomes EU Commissioner for Health and Food Safety, , 13/01/2022
Replies
0
Views
265
EMA
E
F
Buprenorphine: Drug Safety Communication - FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use di
Replies
0
Views
270
FDA
F
F
FDA warns about risks of dental problems associated with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain
Replies
0
Views
246
FDA
F
F
How do I request a Patient Listening Session?
Replies
0
Views
312
FDA
F
F
Untitled Letters 2021
Replies
0
Views
360
FDA
F
F
Summary Metrics of Drug Development Tool Qualification Projects Submitted to FDA
Replies
0
Views
330
FDA
F
F
Food and Drug Administration Reauthorization Act of 2017 (FDARA) Hiring Data
Replies
0
Views
290
FDA
F
F
Public Notification: Tawon Liar mengandung bahan obat tersembunyi
Replies
0
Views
328
FDA
F
F
Drug Supply Chain Security Act (DSCSA)
Replies
0
Views
302
FDA
F
F
Avet Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Tetracycline HCl Capsules USP, 250 mg and 500 mg Due to Failed Dissolution Specificati
Replies
0
Views
284
FDA
F
F
FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain
Replies
0
Views
292
FDA
F
F
FDA warns about risks of dental problems associated with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain
Replies
0
Views
243
FDA
F
F
Drug Safety Communications
Replies
0
Views
312
FDA
F
F
Lohxa LLC Issues Voluntary Nationwide Recall of Senna Syrup 8.8mg/5mL Due to Microbial Contamination
Replies
0
Views
326
FDA
F
E
Preliminary data indicate COVID-19 vaccines remain effective against severe disease and hospitalisation caused by the Omicron variant, , 11/01/2022
Replies
0
Views
315
EMA
E
F
Drug Development Tools: Fit-for-Purpose Initiative
Replies
0
Views
308
FDA
F
F
Hubei Kangzheng Pharmaceutical Co., Ltd. - 616581 - 11/23/2021
Replies
0
Views
273
FDA
F
F
Critical Path Innovation Meetings (CPIM)
Replies
0
Views
304
FDA
F
F
July - September 2021 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)
Replies
0
Views
278
FDA
F
You must log in or register to post here.
Top